期刊文献+

载药中空微球研究进展 被引量:4

Research progress of drug-loaded hollow microspheres
下载PDF
导出
摘要 目的介绍载药中空微球的研究进展。方法对中空微球的制备方法以及体内外漂浮性能的评价方法进行综述。结果该剂型可以延长药物在胃内的滞留时间,提高生物利用度并减少给药次数。结论中空微球是具有开发潜力的漂浮系统,具有广阔的发展前景。 Objective To review the research progress of drug-loaded hollow microspheres.Methods The preparation and floating characterization in vivo and in vitro of the hollow microspheres were introduced on the basis of related references.Results Hollow microspheres have the advantage of prolonging the gastric retention time,enhancing the bioavailability and decreasing dosing frequency.Conclusions Hollow microspheres are considered to be gastric floating drug delivery system with great development potential.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第7期575-580,共6页 Journal of Shenyang Pharmaceutical University
关键词 中空微球 漂浮 多单元 给药系统 hollow microsphere floating multiple-unit drug delivery system
  • 相关文献

参考文献22

  • 1KAWASHIMA Y, NIWA T, TAKEUCHI H, et al. Hollow microspheres for use as a floating controlled drug delivery system in the stomach [ J ]. Journal of Pharmaceutical Sciences, 1992,81 (2) : 135 - 140.
  • 2SATO Y, KAWASHIMA Y, TAKEUCHI H, et al. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method [ J ]. European Journal of Pharmaceutics and Biopharmaceutics, 2003,55(3) :297 -304.
  • 3李晓芳,洪慧,何琳.阿司匹林胃漂浮微球的制备[J].广东药学院学报,2006,22(1):13-15. 被引量:10
  • 4BASAVARAJ B V, DEVESWARAN R, BHARATH S,et al. Hollow microspheres of diclofenac sodium-a gastroretentive controlled delivery system [ J ]. Paki- stan journal of pharmaceutical sciences,2008,21 (4) : 451 - 454.
  • 5JUNYAPRASERT V B, PORNSUWANNAPHA S. Floating properties and release characteristics of hol- low microspheres of acyclovir [ J ]. Drug Delivery, 2008,15(5) :331 -341.
  • 6GARG R, GUPTA G D. Gastroretentive floating mi- crospheres of silymarin:Preparation and in vitro eval- uation [J]. Tropical Journal of Pharmaceutical Re- search,2010,9 ( 1 ) :59 -66.
  • 7SOPPIMATH K S, KULKARNI A R,AMINABHAVI T M. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: Preparation and release characteristics [ J ].Drug De- velopment and Industrial Pharmacy, 2001,27 ( 6 ) : 507 -515.
  • 8魏郁梦,赵领,于明安.盐酸雷尼替丁中空缓释微球的制备及其特性[J].中国医院药学杂志,2007,27(11):1548-1553. 被引量:9
  • 9CROTTS G, PARK T G. Preparation of porous and nonporous biodegradable polymeric hollow micro- spheres [ J ]. Journal of Controlled Release, 1995,35 : 91 - 105.
  • 10GRAVES R A, POOLE D, MOISEYEV R, et al. En- capsulation of indomethacin using coaxial ultrasonic atomization followed by solvent evaporation[ J]. Drug Development and Industrial Pharmacy, 2008,34 (4) : 419 -426.

二级参考文献64

  • 1常青.聚乳酸的合成、结构及性能[J].高分子材料科学与工程,1994,10(1):140-143. 被引量:29
  • 2袁悦,李三鸣,莫凤奎.漂浮药物传递系统的新进展——中空微球[J].沈阳药科大学学报,2005,22(3):235-240. 被引量:3
  • 3Joseph NJ,Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxieam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits[J]. J Controlled Release, 2002,79(1-3) :71 - 79.
  • 4El-Kamel AH, Sokar MS, A1 Gamal SS, et al. Preparation and evaluation of ketoprofen floating oral delivery system[ J ].Int J Pharm ,2001,220(1-2) : 13 - 21.
  • 5Baumgartner S, Kristl J, Vrecer F, et al. Optimisation of floating matrix tablets and evaluation of their gastric residence time[J].Int J Pharm ,2000,195(1-2) : 125 - 135.
  • 6Li SF,Lin SS,Dagg BP, et al. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design[J].Int J Pharm ,2003,253(1-2) : 13 - 22.
  • 7Whitehead L,Collett JH, Fell JT. Amoxycillin release from a floating dosage form based on alginates[J].Int J Pharm,2000,210( 1-2):45 - 49.
  • 8Iannuccelli V, Coppi G, Bernabei MT, et al. Air compartment multiple-unit system for prolonged gastric residence. Part I.Formulation study[J].Int J Pharm, 1998,174(1-2) :47 - 54.
  • 9El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microeapsules for oral use: comparison with non-floating chitosan microspheres[J]. Int J Pharm, 2002,249(1-2) :7 - 21.
  • 10Sato Y, Kawashima Y, Takeuchi H, et al. In vitro and in vivo evaluation of rlboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans[J]. lnt J Pharm,2004,275(1-2) :97 - 107.

共引文献28

同被引文献39

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部